Literature DB >> 2737376

A comparative study of postnatally-acquired cerebral palsy in Cape Town.

L J Arens1, C D Molteno.   

Abstract

The importance of socio-economic conditions in the causation of postnatally-acquired cerebral palsy has not been stressed in previous studies. A comparative survey was undertaken in Cape Town, South Africa. Three ethnic groups were compared--white, coloured (mixed ancestry) and black. The percentage of postnatally-acquired cerebral palsy in these groups was 13.2, 24.0 and 36.1 per cent, respectively. These figures can be explained by the differing socio-economic conditions of each group, the white group belonging to the highest socio-economic stratum and the black group to the lowest. The main causes of postnatally-acquired cerebral palsy were cerebral infections (particularly meningitis), cerebral trauma and cerebrovascular accidents. The proportion in each group, the main causal factors, age at onset, types of cerebral palsy and intellectual status are similar to those of most previous studies.

Entities:  

Mesh:

Year:  1989        PMID: 2737376     DOI: 10.1111/j.1469-8749.1989.tb03985.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

Review 1.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

Review 2.  Cerebral palsy--an increasing contributor to severe mental retardation?

Authors:  A Nicholson; E Alberman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

Review 3.  Neurologic Correlates of Gait Abnormalities in Cerebral Palsy: Implications for Treatment.

Authors:  Joanne Zhou; Erin E Butler; Jessica Rose
Journal:  Front Hum Neurosci       Date:  2017-03-17       Impact factor: 3.169

4.  A diagnostic, monitoring, and predictive tool for patients with complex valvular, vascular and ventricular diseases.

Authors:  Zahra Keshavarz-Motamed
Journal:  Sci Rep       Date:  2020-04-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.